Trial Details
COMPLETEDBasic Information
| Clinical ID | c3352 |
|---|---|
| Identifier | NCT02185014 |
| Trial Title | Open Label Study to Evaluate Long Term Efficacy, Safety and Tolerability of Repeated Dosing in Subjects With Crohn's Disease and Who Participated and Successfully Completed M14-115 |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Adalimumab |
Participant Information
| Sponsor | AbbVie |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2014-08-12 |
|---|---|
| Primary Completion Date | 2017-11-03 |
| Completion Date | 2017-11-03 |